Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
Allakos logo in transparent PNG and vectorized SVG formats
Richmond, Virginia, USA - 8 May 2019: Illustrative Editorial of Allakos ...
Allakos surges 44% as biotech buyout rumors continue to grow - Warrior ...
Allakos Inc. to be Acquired by Concentra Biosciences for $0.33 Per ...
Allakos Announces Positive Results from its Ongoing Phase 1 Trial of ...
Allakos raises $127.8 million in upsized IPO that tops target range ...
Allakos Reaches Corporate Endpoint with Concentra Acquisition - Stocks ...
Allakos Logo Transparent PNG - 3000x1484 - Free Download on NicePNG
Allakos Reaches Corporate Endpoint with Concentra Acquisition
Allakos (ALLK) Stock Price & Overview
Allakos | A Biopharma Success Story | Alta Partners
Allakos Inc Company Profile - Allakos Inc Overview - GlobalData
Allakos Announces Initiation of Phase 2b Clinical Trial of
Allakos Inc. Enters into Agreement to Be Acquired by Concentra ...
Allakos (ALLK) - Cash on Hand
Allakos is acquired by Concentra Biosciences. – Medthority
Allakos completes merger with Concentra Biosciences By Investing.com
Why Is Allakos Soaring Today?
Allakos axes program, lays off 75% of staff and seeks strategic ...
Allakos Shares Tumble on Phase 3 Data of Eosinophilic Gastrointestinal ...
Allakos drops lead asset after midphase flops join litany of letdowns ...
China. 02nd Oct, 2025. In this photo illustration, the logo of Allakos ...
Allakos Announces Layoffs After Phase 1 Trial Misses Goals | American ...
Allakos Announces Initiation of Phase 2b Clinical Trial of Subcutaneous ...
Investigation into Allakos Inc.'s Merger with Concentra Biosciences by ...
Allakos Inc. Stock Overview — ALLK Summary & Analysis — Roic AI
Allakos is Crashing today, Tests Failed - TechStory
Allakos Announces New Antibody that Prevents Anaphylaxis in Humanized ...
Allakos to Be Acquired by Concentra Biosciences in All-Cash Deal | ALLK ...
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in ...
Buy Allakos Inc Stock – ALLK Stock Quote Today & Investment Insights ...
Allakos Inc. - AnnualReports.com
ALLK Stock: Is It All Over for Allakos After the Trial Results?
Allakos Faces Restructuring and Strategic Review After Failed AK006 ...
Why Allakos Stock Skyrocketed 154% in August | The Motley Fool
What are the Porter's Five Forces of Allakos Inc. (ALLK)? – DCFmodeling.com
Why Is Allakos (ALLK) Stock Down 57% Today? | InvestorPlace
Allakos Inc.'s phase 1 trial of AK006 in chronic spontaneous urticaria ...
Allakos - Liquidation Auction - Equipment Auctions | HGP Industrial Auction
Shareholder Alert: The Ademi Firm Investigates Whether Allakos Inc. Is ...
Allakos Trial Halted: Stock Plunge Sends Shockwaves in Biotech ...
Allakos Inc on LinkedIn: The New England Journal of Medicine publishes ...
Tang Capital’s Concentra nabs a win, making a deal to buy Allakos
Allakos Faces Restructuring and Strategic Review After Trial Failure ...
Allakos Ad 2 AD
Rx Rundown: BridgeBio Pharma, Vertex Pharmaceuticals, Allakos and more
Allakos Inc | LinkedIn
Allakos Jobs | Levels.fyi
ALLAKOS INC price forecast, (Allakos Inc) analysis today and 2024 ...
Allakos (ALLK) Plummets 60% on Ending Development of Lead Drug
Allakos Inc. (ALLK) 2021年年度报告「NASDAQ」.pdf_三个皮匠报告
ALLK - Allakos Inc. Stock - Stock Price, Institutional Ownership ...
Is Allakos Inc. (ALLK) A Good Stock To Buy?
Allakos Inc #IPO Preview ($ALLK) – IPO Boutique
Allakos - Concentra Biosciences | Transaction Details
Redwood City biotech Allakos' stock soars on report of possible sale ...
Allakos, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Bay Area biotech firm suddenly on brink of collapse after trial flops
Pipeline & products
Biotech Companies With the Highest Median Pay for Employees - Business ...
Logos of biotech companies
Bay Area Newsletter: Allakos, Allogene, BioMarin, Cellares, Corcept ...
Bay Area Biotech at a Crossroads: Innovation Amid Industry Challenges
Allakos' positive results: first big step into GI space
Globus Medical Concludes $250 Million Acquisition of Nevro Corp: A ...
Allakos-347 - Form4
Slide 29
Slide 3
$ALLK (Allakos) History repeats itself. The bounce is inevitable. : r ...
Slide 30
Vernal Keratoconjunctivitis Pipeline Analysis & Clinical Trials, 2025 ...
CSU Pipeline Watch: First Patient Dosed in Phase 1 Trial of Allakos’s ...
Slide 7
After flunking studies last year, Allakos' failed phase 3 EoDyssey ...
Allakos宣布其正在健康志愿者中进行的AK006 1期试验结果呈阳性，AK006在肥大细胞上表现出高受体占有率和良好的安全性-动脉网
Potential of IPF Treatment Now in Clinical Trial Supported by Early Data
Become a Partner - TMS - The Mast Cell Disease Society, Inc
Used Laboratory Equipment: Outfit Your Lab for a Fraction
Allakos公布AK002两项研究顶线结果
Corporate Partners | National Eczema Association | Supporters
Firm Overview & History | Alta Partners
